Weihai Baihe Stock Hits Day Low of CNY 39.72 Amid Price Pressure

Weihai Baihe Biology Technological Co., Ltd. has experienced a significant decline today, with the stock dropping by 9.99% as of August 21, 2026. The stock reached an intraday low of CNY 39.72, reflecting a challenging market environment for the small-cap pharmaceuticals and biotechnology company. In terms of performance metrics, Weihai Baihe's one-day performance contrasts sharply with the China Shanghai Composite, which saw a slight increase of 0.04%. Over the past week, the stock has shown a modest gain of 0.66%, while its one-month performance stands at a notable 27.47%. However, the longer-term outlook appears less favorable, with a year-to-date decline of 7.56% and a one-year performance down by 9.83%. Financial indicators reveal that the company has faced difficulties in achieving sustainable growth, with net sales increasing at an annual rate of only 7.35% over the last five years. Additionally, the operating profit has decreased by 9.37% during the same period. The company's market capitalization is currently CNY 1,315 million, and it maintains a price-to-earnings ratio of 16.00.